{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:13:17Z","timestamp":1788585197097,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-75-30008-P"],"award-info":[{"award-number":["19-75-30008-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004285","name":"Saint Petersburg State University of Aerospace Instrumentation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pbb.2024.173817","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T21:23:29Z","timestamp":1720733009000},"page":"173817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Ligands of the trace amine-associated receptors (TAARs): A new class of anxiolytics"],"prefix":"10.1016","volume":"242","author":[{"given":"Yazen","family":"Alnefeesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Sukhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul R.","family":"Gainetdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2024.173817_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neubiorev.2021.09.020","article-title":"Trace amine-associated receptor 1 (TAAR1): potential application in mood disorders: a systematic review","volume":"131","author":"Alnefeesi","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2024.173817_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuroimage.2014.01.017","article-title":"BNST neurocircuitry in humans","volume":"91","author":"Avery","year":"2014","journal-title":"NeuroImage"},{"key":"10.1016\/j.pbb.2024.173817_bb0015","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3928\/00485713-20081101-01","article-title":"Anxiety disorders with comorbid substance use disorders: diagnostic and treatment considerations","volume":"38","author":"Back","year":"2008","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.pbb.2024.173817_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pharmthera.2017.07.002","article-title":"Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges","volume":"180","author":"Berry","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2024.173817_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.11.026","article-title":"Pharmacology of anxiety or pharmacology of elevated plus maze?","volume":"89","author":"Bespalov","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0030","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/ijms23063127","article-title":"Discovery of novel trace amine-associated receptor 5 (TAAR5) antagonists using a deep convolutional neural network","volume":"23","author":"Bon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173817_bb0035","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173817_bb0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fphar.2018.00222","article-title":"The trace amine-associated receptor 1 agonist 3-Iodothyronamine induces biased signaling at the serotonin 1b receptor","volume":"9","author":"Br\u00e4unig","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173817_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109398","article-title":"Canalization and plasticity in psychopathology","volume":"226","author":"Carhart-Harris","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173817_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2167702613497473","article-title":"The p factor: one general psychopathology factor in the structure of psychiatric disorders?","volume":"2","author":"Caspi","year":"2014","journal-title":"Clin. Psychol. Sci. J. Assoc. Psychol. Sci."},{"key":"10.1016\/j.pbb.2024.173817_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castr\u00e9n","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2024.173817_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2024.173817_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/npp.2009.109","article-title":"Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety","volume":"35","author":"Davis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173817_bb0070","doi-asserted-by":"crossref","DOI":"10.1080\/23262133.2016.1231160","article-title":"Cacna1c: protecting young hippocampal neurons in the adult brain","volume":"3","author":"De Jes\u00fas-Cort\u00e9s","year":"2016","journal-title":"Neurogenesis"},{"key":"10.1016\/j.pbb.2024.173817_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1530\/JME-15-0003","article-title":"3-iodothyronamine differentially modulates \u03b1-2A-adrenergic receptor-mediated signaling","volume":"54","author":"Dinter","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.pbb.2024.173817_bb0080","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108373","article-title":"Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice","volume":"182","author":"Efimova","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173817_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.847410","article-title":"Trace amine-associated receptor 2 is expressed in the limbic brain areas and is involved in dopamine regulation and adult neurogenesis","volume":"16","author":"Efimova","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173817_bb0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/mol.111.073304","article-title":"Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor","volume":"80","author":"Espinoza","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173817_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00018","article-title":"Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission","volume":"13","author":"Espinoza","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pbb.2024.173817_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.117.015305","article-title":"Trace amines and their receptors","volume":"70","author":"Gainetdinov","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2024.173817_bb0110","article-title":"Pharmacotherapy of anxiety disorders: current and emerging treatment options","volume":"11","author":"Garakani","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.pbb.2024.173817_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2011.11.046","volume":"202","author":"Gaszner","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173817_bb0120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuropharm.2003.11.031","article-title":"Inhibitory effects of trace amines on rat midbrain dopaminergic neurons","volume":"46","author":"Geracitano","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173817_bb0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuroimage.2017.03.007","article-title":"Intrinsic functional connectivity of the central nucleus of the amygdala and bed nucleus of the Stria terminalis","volume":"168","author":"Gorka","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.pbb.2024.173817_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40337-022-00654-2","article-title":"Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature","volume":"10","author":"Hambleton","year":"2022","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.pbb.2024.173817_bb0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopsych.2014.12.003","article-title":"Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies","volume":"78","author":"Hammack","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0140","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.euroneuro.2015.08.011","article-title":"Trace amine-associated receptor 1 activation silences GSK3\u03b2 signaling of TAAR1 and D2R heteromers","volume":"25","author":"Harmeier","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2024.173817_bb0145","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/npp.2015.85","article-title":"Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors","volume":"40","author":"Hill","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173817_bb0150","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41380-023-02285-8","article-title":"Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial","volume":"28","author":"Johansen","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/cells11111813","article-title":"Expression of trace amine-associated receptors in the murine and human Hippocampus based on public transcriptomic data","volume":"11","author":"Katolikova","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pbb.2024.173817_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","article-title":"Comorbidity of mood and anxiety disorders","volume":"12","author":"Kaufman","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pbb.2024.173817_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pbb.2024.173817_bb0170","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1911772","article-title":"A non\u2013D2-receptor-binding drug for the treatment of schizophrenia","volume":"382","author":"Koblan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2024.173817_bb0175","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/biom12111650","article-title":"Discovery of trace amine-associated receptor 1 (TAAR1) agonist 2-(5-(4\u2032-Chloro-[1,1\u2032-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)Ethan-1-amine (LK00764) for the treatment of psychotic disorders","volume":"12","author":"Krasavin","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.pbb.2024.173817_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/13543784.2023.2206559","article-title":"Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials","volume":"32","author":"Le","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pbb.2024.173817_bb0185","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/mp.2016.1","article-title":"Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders","volume":"21","author":"Lebow","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0190","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/mp.2012.71","article-title":"Forebrain elimination of cacna1c mediates anxiety-like behavior in mice","volume":"17","author":"Lee","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0195","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0006-16.2016","article-title":"The neuropsychiatric disease-associated gene cacna1c mediates survival of young hippocampal neurons","volume":"3","author":"Lee","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.pbb.2024.173817_bb0200","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.3390\/ijms21239103","article-title":"2-Phenylethylamine (PEA) ameliorates corticosterone-induced depression-like phenotype via the BDNF\/TrkB\/CREB signaling pathway","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173817_bb0205","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/jpet.107.132647","article-title":"Trace amine-associated receptor 1 modulates dopaminergic activity","volume":"324","author":"Lindemann","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173817_bb0210","article-title":"Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms","volume":"116236","author":"Peng","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173817_bb0215","first-page":"914","volume":"397","author":"Penninx","year":"2021","journal-title":"Anxiety disorders. Lancet Lond. Engl."},{"key":"10.1016\/j.pbb.2024.173817_bb0220","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1073\/pnas.181356198","article-title":"Following the trace of elusive amines","volume":"98","author":"Premont","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2024.173817_bb0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature09856","article-title":"Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor","volume":"470","author":"Ressler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173817_bb0230","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","article-title":"TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity","volume":"108","author":"Revel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2024.173817_bb0235","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173817_bb0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(95)01098-X","article-title":"Beta-Phenylethylamine regulation of dopaminergic nigrostriatal cell activity","volume":"703","author":"Rodriguez","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173817_bb0245","first-page":"427","article-title":"A review of studies concerning treatment adherence of patients with anxiety disorders","volume":"5","author":"Santana","year":"2011","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.pbb.2024.173817_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13643-020-1274-3","article-title":"Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis","volume":"9","author":"Semahegn","year":"2020","journal-title":"Syst. Rev."},{"key":"10.1016\/j.pbb.2024.173817_bb0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(01)01562-X","article-title":"Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)","volume":"435","author":"Spooren","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173817_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuroscience.2004.06.015","article-title":"Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus","volume":"128","author":"Sullivan","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173817_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105271","article-title":"T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex","volume":"151","author":"Tozzi","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2024.173817_bb0270","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.3390\/ijms22168802","article-title":"Pattern of TAAR5 expression in the human brain based on transcriptome datasets analysis","volume":"22","author":"Vaganova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173817_bb0275","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/biom12091259","article-title":"Public transcriptomic data Meta-analysis demonstrates TAAR6 expression in the mental disorder-related brain areas in human and mouse brain","volume":"12","author":"Vaganova","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.pbb.2024.173817_bb0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1037\/0735-7044.120.2.324","article-title":"Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear","volume":"120","author":"Waddell","year":"2006","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173817_bb0285","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s002130100913","article-title":"Light-enhanced startle: further pharmacological and behavioral characterization","volume":"159","author":"Walker","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173817_bb0290","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","article-title":"The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia","volume":"6","author":"Wolinsky","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pbb.2024.173817_bb0295","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13075","article-title":"Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects","volume":"27","author":"Wu","year":"2022","journal-title":"Addict. Biol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T17:15:01Z","timestamp":1722014101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305724001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"alternative-id":["S0091305724001114"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173817","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligands of the trace amine-associated receptors (TAARs): A new class of anxiolytics","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"173817"}}